The efficacy of azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in patients with Crohn’s disease remains uncertain
- 1 September 2004
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 127 (3) , 990-993
- https://doi.org/10.1053/j.gastro.2004.07.037
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Mesalamine for the prevention of postoperative recurrence: Is nearly there the same as being there?Gastroenterology, 2000
- Low-dose budesonide treatment for prevention of postoperative recurrence of Crohnʼs diseaseEuropean Journal of Gastroenterology & Hepatology, 1999
- A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study GroupGastroenterology, 1997
- Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohnʼs diseaseEuropean Journal of Gastroenterology & Hepatology, 1996
- Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's diseaseGastroenterology, 1995
- Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's diseaseGastroenterology, 1995
- Oral mesalazine (5‐aminosalicylic acid; Asacol) for the prevention of post‐operative recurrence of Crohn's diseaseAlimentary Pharmacology & Therapeutics, 1994
- Treatment of Crohn's Disease with 6-MercaptopurineNew England Journal of Medicine, 1980
- Low dose steroids and clinical relapse in Crohn's disease: a controlled trial.Gut, 1978
- The Long-term Prophylactic Effect of Salazosulfapyridine (SalazopyrinR) in Primarily Resected Patients with Crohn's DiseaseScandinavian Journal of Gastroenterology, 1978